Target intelligence / Profile preview

Perfluorooctane sulfonic acid (PFOS)

Target
PFOS
Molecular classification
Perfluoroalkyl sulfonic acid, Per- and polyfluoroalkyl substance (PFAS), Endocrine disruptor, Xenobiotic
01

Overview

Perfluorooctane sulfonic acid (PFOS) is a synthetic, fully fluorinated organic acid belonging to the class of per- and polyfluoroalkyl substances (PFAS). It is not a therapeutic target but rather a persistent environmental pollutant and toxicant known for its extreme chemical stability and bioaccumulative properties [3, 15]. PFOS exerts its biological effects by interacting with various nuclear receptors, most notably acting as an agonist for the peroxisome proliferator-activated receptor alpha (PPAR-alpha) and the orphan nuclear receptor 4A1 (NR4A1) [1, 14]. These interactions lead to significant disruptions in lipid metabolism, endocrine function, and immune responses [4, 9]. Clinically, elevated PFOS levels are associated with hepatotoxicity, hypercholesterolemia, thyroid dysfunction, and impaired vaccine response [8, 11]. While not a drug target, its elimination from the body can be accelerated by bile acid sequestrants like cholestyramine, which interrupt its enterohepatic circulation [8, 12]. Its persistence in the environment and human body has led to its classification as a 'forever chemical' and its inclusion in the Stockholm Convention on Persistent Organic Pollutants [15]. Research continues to investigate its role as a potential carcinogen, with the IARC classifying it as possibly carcinogenic to humans [18].

Other names
PerfluorooctanesulfonateHeptadecafluorooctane-1-sulfonic acid1-Octanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-PFOS
02

Mechanism of action

Bile acid sequestrants like cholestyramine bind to PFOS in the gastrointestinal tract, preventing its reabsorption and interrupting its enterohepatic circulation, thereby increasing its fecal excretion [8, 12].

03

Biological functions

Lipid metabolism disruptionEndocrine disruptionImmune suppression
04

Disease associations

HepatotoxicityHypercholesterolemiaThyroid diseaseCancerDevelopmental disorderImmune suppression
05

Safety considerations

BioaccumulationEnvironmental persistenceDevelopmental toxicityImmunotoxicityHepatotoxicity
06

Interacting drugs

Cholestyramine

2 more in the full profile.

07

Biomarkers

Serum PFOS concentrationAlanine aminotransferase (ALT)Total cholesterol

Beyond the preview

Go deeper on Perfluorooctane sulfonic acid (PFOS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Perfluorooctane sulfonic acid (PFOS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call